CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Nitrosative stress drives heart failure with preserved ejection fraction Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead? Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure HFpEF: From Mechanisms to Therapies Functional Impairment and Medication Burden in Adults With Heart Failure Heart Failure With Preserved Ejection Fraction in the Young

Original ResearchDecember 11, 2018 Vol 138, Issue 24

JOURNAL:Circulation. Article Link

Heart Failure With Preserved Ejection Fraction in the Young

J Tromp , MR MacDonald, CSP Lam et al. Keywords: HFpEF; age; obesity

FULL TEXT PDF